Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence

JH Hayes, MJ Barry - Jama, 2014 - jamanetwork.com
Importance Prostate cancer screening with the prostate-specific antigen (PSA) test remains
controversial. Objective To review evidence from randomized trials and related modeling …

[HTML][HTML] Dietary factors and prostate cancer development, progression, and reduction

M Oczkowski, K Dziendzikowska… - Nutrients, 2021 - mdpi.com
Due to the constantly increasing number of cases, prostate cancer has become one of the
most important health problems of modern societies. This review presents the current …

Early detection of prostate cancer: AUA Guideline

HB Carter, PC Albertsen, MJ Barry, R Etzioni… - The Journal of …, 2013 - auajournals.org
Purpose: The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …

American Cancer Society prostate cancer survivorship care guidelines

TA Skolarus, AMD Wolf, NL Erb… - CA: a cancer journal …, 2014 - Wiley Online Library
Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in
number and represent 1 in 5 of all cancer survivors in the United States. While guidelines …

Prostate cancer in young men: an important clinical entity

CA Salinas, A Tsodikov, M Ishak-Howard… - Nature Reviews …, 2014 - nature.com
Prostate cancer is considered a disease of older men (aged> 65 years), but today over 10%
of new diagnoses in the USA occur in young men aged≤ 55 years. Early-onset prostate …

Prevention of prostate cancer morbidity and mortality: primary prevention and early detection

MJ Barry, LH Simmons - Medical Clinics, 2017 - medical.theclinics.com
Disclosure: Dr MJ Barry is President of the Informed Medical Decisions Foundation, a part of
Healthwise, where he is also Chief Science Officer. Healthwise is a 501 (c) 3 nonprofit …

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population

RJ Karnes, EJ Bergstralh, E Davicioni… - The Journal of …, 2013 - auajournals.org
Purpose: Patients with locally advanced prostate cancer after radical prostatectomy are
candidates for secondary therapy. However, this higher risk population is heterogeneous …

[HTML][HTML] Global incidence of prostate cancer in developing and developed countries with changing age structures

JYC Teoh, HW Hirai, JMW Ho, FCH Chan, KKF Tsoi… - PloS one, 2019 - journals.plos.org
To investigate the global incidence of prostate cancer with special attention to the changing
age structures. Data regarding the cancer incidence and population statistics were retrieved …

Trends in prostate cancer in the United States

OW Brawley - Journal of the National Cancer Institute …, 2012 - academic.oup.com
Abstract In the United States, prostate cancer is the most commonly diagnosed non–skin
cancer and the second leading cause of cancer death. The American Cancer Society …

Point-of-Care prostate specific antigen testing: examining translational progress toward clinical implementation

S Garg, A Sachdeva, M Peeters, J McClements - ACS sensors, 2023 - ACS Publications
Prostate cancer (PCa) is the second most common male cancer and is attributable to over
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …